All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

118

Reset

118 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • PG-011GelPG-011Gel 3%Phase 31 trial

    Prime Gene Therapeutics Co., Ltd. · Atopic Dermatitis

  • prolgolimabBCD-100, FortecaPhase 31 trial

    Biocad · Melanoma, Melanoma (Skin), Melanoma Stage III

  • pz-celEB-101 Surgical application of RDEB woundsPhase 31 trial

    Abeona Therapeutics, Inc · Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB

  • QL2108Phase 31 trial

    Qilu Pharmaceutical Co., Ltd. · Atopic Dermatitis

  • TTAX01Phase 31 trial

    BioTissue Holdings, Inc · Diabetic Foot Infection, Non-healing Wound, Non-healing Diabetic Foot Ulcer

  • NM8074Phase 28 trials

    NovelMed Therapeutics · Paroxysmal Nocturnal Hemoglobinuria, Dermatomyositis, PNH - Paroxysmal Nocturnal Hemoglobinuria

  • AK139Phase 26 trials

    Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria

  • Descartes-08Phase 24 trials

    Cartesian Therapeutics · Myasthenia Gravis, Generalized, Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV)

  • EVO756Phase 24 trials

    Evommune, Inc. · Migraine, Chronic Inducible Urticaria, Atopic Dermatitis

  • ENV-294Phase 23 trials

    Enveda Therapeutics · Atopic Dermatitis (AD), Atopic Dermatitis, Asthma

  • GalvokimigUCB9741Phase 23 trials

    UCB · Chronic Obstructive Pulmonary Disease With Chronic Bronchitis, Atopic Dermatitis, Non-cystic Fibrosis Bronchiectasis

  • GIA632Phase 23 trials

    Novartis · Atopic Dermatitis, Non-segmental Vitiligo, Cutaneous Lichen Planus

  • IMG-007Phase 23 trials

    Inmagene LLC · Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema

  • KT-621Phase 23 trials

    Kymera Therapeutics, Inc. · Eosinophilic Asthma, Atopic Dermatitis, Asthma (Diagnosis)

  • LT-002-158Phase 23 trials

    Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)

  • QLS12010Phase 23 trials

    Qilu Pharmaceutical Co., Ltd. · Adults With Moderate-to-severe Hidradenitis Suppurativa, Moderate-to-severe Atopic Dermatitis, Rheumatoid Arthritis (RA)

  • RSS0393Phase 23 trials

    Jiangsu HengRui Medicine Co., Ltd. · Psoriatic Subjects, Plaque Psoriasis in Children, Plaque Psoriasis in Adolescents

  • AB-101zabalafinPhase 22 trials

    Alphyn Biologics · Atopic Dermatitis (Eczema), Atopic Dermatitis Eczema, Atopic Dermatitis

  • ADX-914bempikibartPhase 22 trials

    Q32 Bio Inc. · Atopic Dermatitis, Alopecia Areata

  • AK120JAK inhibitor users need to double the initial dosePhase 22 trials

    Akeso · Atopic Dermatitis

  • APG777Phase 22 trials

    Apogee Therapeutics, Inc. · Atopic Dermatitis

  • CadefrecitinibGLPG3667Phase 22 trials

    Lakefront Biotherapeutics NV · Dermatomyositis, Systemic Lupus Erythematosus

  • CamoteskimabAPL-9109Phase 22 trials

    Apollo Therapeutics Ltd · Atopic Dermatitis, Atopic, Dermatitis

  • CGB-500Phase 22 trials

    CAGE Bio Inc. · Atopic Dermatitis (AD)

  • DNA VaccinePhase 22 trials

    NEC Bio B.V · Triple Negative Breast Cancer, Malignant Melanoma, Melanoma (Skin)

  • FB825Phase 22 trials

    Oneness Biotech Co., Ltd. · Allergic Asthma, Atopic Dermatitis

  • HB0043Phase 22 trials

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Acne Vulgaris, Hidradenitis Suppurativa

  • IfetrobanPhase 22 trials

    Cumberland Pharmaceuticals · Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited

  • JNJ-95597528Phase 22 trials

    Johnson & Johnson (Janssen) · Dermatitis, Atopic, Asthma

  • JYP0061Experimental Drug GroupPhase 22 trials

    Guangzhou JOYO Pharma Co., Ltd · Moderate-to-severe Atopic Dermatitis, Neuromyelitis Optica Spectrum Disorders

  • ModzatinibATI-2138Phase 22 trials

    Aclaris Therapeutics, Inc. · Lichen Planus, Atopic Dermatitis

  • VIS954Phase 22 trials

    Otsuka · Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Inflammatory Skin Diseases

  • XKH001InjectionXKH001Phase 22 trials

    Zhejiang Kanova Biopharmaceutical Co., LTD · COPD, Atopic Dermatitis

  • AGLE-102Phase 21 trial

    Aegle Therapeutics · Dystrophic Epidermolysis Bullosa

  • AT-004Phase 21 trial

    Arctic Therapeutics · Acne Vulgaris on the Face

  • ATB1651-102Phase 21 trial

    AmtixBio Co., Ltd. · Onychomycosis

  • ATI-045Phase 21 trial

    Aclaris Therapeutics, Inc. · Atopic Dermatitis, Atopic, Dermatitis

  • AZD6750Phase 21 trial

    AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)

  • B244Phase 21 trial

    AOBiome LLC · Acne Vulgaris

  • BI-1607Phase 21 trial

    BioInvent International AB · Melanoma Metastatic, Melanoma of Skin, Melanoma BRAF V600E/K Mutated

  • BimiralisibPhase 21 trial

    TORQUR · Actinic Keratosis

  • CPL500036Phase 21 trial

    Celon Pharma SA · Parkinson Disease, Dyskinesia, Medication-Induced

  • ELU42Phase 21 trial

    Eluciderm Inc · Diabetic Foot Ulcer, Wagner Grade 1 - 2, Chronic Wound

  • ENV-501Phase 21 trial

    Hummingbird Bioscience · Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer

  • EVO301Phase 21 trial

    Evommune, Inc. · Atopic Dermatitis (AD), Eczema, Eczema Atopic Dermatitis

  • GHZ339Phase 21 trial

    Novartis · Atopic Dermatitis

  • HL-300Phase 21 trial

    Hangzhou Highlightll Pharmaceutical Co., Ltd · Atopic Dermatitis

  • HW211026Phase 21 trial

    Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Actinic Keratosis

  • HXN6005Phase 21 trial

    Helixon Biotechnology (Suzhou) Co., Ltd · Health Adult Subjects, Atopic Dermatitis (AD)

  • IBI3002Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis

NewerPage 2 of 3Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.